Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Pulmonary Hypertension

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 129 articles:
HTML format
Text format



Single Articles


    July 2018
  1. QUADERY SR, Swift AJ, Billings C, Thompson A, et al
    The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2018 Jul 12. pii: 13993003.00589-2018.
    PubMed     Text format     Abstract available


  2. BELLAYE PS, Yanagihara T, Granton E, Sato S, et al
    Macitentan reduces progression of TGF-beta1-induced pulmonary fibrosis and pulmonary hypertension.
    Eur Respir J. 2018 Jul 5. pii: 13993003.01857-2017.
    PubMed     Text format    


    May 2018
  3. KING CS, Brown AW, Shlobin OA, Weir N, et al
    Prevalence and Impact of WHO Group 3 Pulmonary Hypertension in Advanced Idiopathic Nonspecific Interstitial Pneumonia.
    Eur Respir J. 2018 May 17. pii: 13993003.00545-2018.
    PubMed     Text format    


  4. GUAZZI M
    Partitioning of pulmonary vascular resistances in group 2 pulmonary hypertension: insightful suggestions for bridging haemodynamics to underlying mechanisms.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    April 2018
  5. HOEPER MM
    Chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: to screen or not to screen?
    Eur Respir J. 2018;51.
    PubMed     Text format    


    March 2018
  6. GERGES C, Gerges M, Fesler P, Maria Pistritto A, et al
    In-depth hemodynamic phenotyping of pulmonary hypertension due to left heart disease.
    Eur Respir J. 2018 Mar 29. pii: 13993003.00067-2018.
    PubMed     Text format     Abstract available


  7. COGHLAN G, Wolf M, Distler O, Denton CP, et al
    Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis.
    Eur Respir J. 2018 Mar 21. pii: 13993003.01197-2017.
    PubMed     Text format     Abstract available


  8. BONNET S, Boucherat O
    The ROS controversy in hypoxic pulmonary hypertension revisited.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  9. OLSCHEWSKI H, Kovacs G, Herve P
    Pulmonary capillary recruitment in exercise and pulmonary hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  10. LANGLEBEN D, Orfanos SE
    Pulmonary capillary recruitment in exercise and pulmonary hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    February 2018
  11. CARAVITA S, Dewachter C, Soranna D, Carolino D'Araujo S, et al
    Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis.
    Eur Respir J. 2018 Feb 8. pii: 13993003.02427-2017.
    PubMed     Text format    


  12. PAK O, Scheibe S, Esfandiary A, Gierhardt M, et al
    Impact of the mitochondria-targeted antioxidant MitoQ on hypoxia-induced pulmonary hypertension.
    Eur Respir J. 2018 Feb 1. pii: 13993003.01024-2017.
    PubMed     Text format     Abstract available


  13. HSU S, Tedford RJ
    Will we be singing a different tune on combined post- and pre-capillary pulmonary hypertension?
    Eur Respir J. 2018;51.
    PubMed     Text format    


  14. VACHIERY JL, Delcroix M, Al-Hiti H, Efficace M, et al
    Macitentan in pulmonary hypertension due to left ventricular dysfunction.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


    January 2018
  15. TRAMPER J, Nossent EJ, Lely RJ, Krouwels FH, et al
    Balloon pulmonary angioplasty in sarcoid-related pulmonary hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  16. COTTIN V, Price LC, Valenzuela C
    The unmet medical need of pulmonary hypertension in idiopathic pulmonary fibrosis.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  17. KUMAR R, Graham B
    How does inflammation contribute to pulmonary hypertension?
    Eur Respir J. 2018;51.
    PubMed     Text format    


    October 2017
  18. BAUGHMAN RP, Shlobin OA
    Treatment of sarcoidosis-associated pulmonary hypertension: so close, and yet so far.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  19. DEGANO B, Soumagne T, Delaye T, Berger P, et al
    Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosis.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  20. BOUCLY A, Cottin V, Nunes H, Jais X, et al
    Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    September 2017
  21. WEATHERALD J, Boucly A, Lau E, Godinas L, et al
    Are indexed values better for defining exercise pulmonary hypertension?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  22. MULLIN CJ, Hsu S, Amancherla K, Wand A, et al
    Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension.
    Eur Respir J. 2017;50.
    PubMed     Text format    


    August 2017
  23. HOEPER MM, Kramer T, Pan Z, Eichstaedt CA, et al
    Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    July 2017
  24. BOGAARD HJ
    Hypoxic pulmonary vasoconstriction in COPD-associated pulmonary hypertension: been there, done that?
    Eur Respir J. 2017;50.
    PubMed     Text format    


    June 2017
  25. OLSSON KM, Wiedenroth CB, Kamp JC, Breithecker A, et al
    Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    May 2017
  26. JOUNEAU S, Ballerie A, Kerjouan M, Demant X, et al
    Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  27. SANGES S, Prevotat A, Fertin M, Terriou L, et al
    Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  28. KLOK FA, Hoeper MM
    Predicting recurrent pulmonary embolism and chronic thromboembolic pulmonary hypertension: one more way to skin the cat.
    Eur Respir J. 2017;49.
    PubMed     Text format    


    March 2017
  29. NEDER JA, Berton DC, Arbex FF, Alencar MC, et al
    Physiological and clinical relevance of exercise ventilatory efficiency in COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    February 2017
  30. SCHERRER U, Verges S
    Sleep apnoea and pulmonary hypertension in high-altitude dwellers: more than an association?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  31. SIMONNEAU G, Hoeper MM
    Evaluation of the incidence of rare diseases: difficulties and uncertainties, the example of chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  32. ENDE-VERHAAR YM, Cannegieter SC, Vonk Noordegraaf A, Delcroix M, et al
    Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  33. NAKHLEH MK, Haick H, Humbert M, Cohen-Kaminsky S, et al
    Volatolomics of breath as an emerging frontier in pulmonary arterial hypertension.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    December 2016
  34. LATSHANG TD, Furian M, Aeschbacher SS, Ulrich S, et al
    Association between sleep apnoea and pulmonary hypertension in Kyrgyz highlanders.
    Eur Respir J. 2016 Dec 22. pii: 1601530. doi: 10.1183/13993003.01530-2016.
    PubMed     Text format     Abstract available


    November 2016
  35. RIOU M, Seferian A, Savale L, Chaumais MC, et al
    Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity.
    Eur Respir J. 2016;48:1517-1519.
    PubMed     Text format    


    October 2016
  36. EID-LIDT G, Gaspar J, Sandoval J, Gonzalez-Pacheco H, et al
    Persistent pulmonary hypertension and right ventricular function after percutaneous mechanical thrombectomy in severe acute pulmonary embolism.
    Eur Respir J. 2016 Oct 20. pii: ERJ-00910-2016. doi: 10.1183/13993003.00910-2016
    PubMed     Text format    


    September 2016

  37. "New potential diagnostic biomarkers for pulmonary hypertension." Svenja L. Tiede, Henning Gall, Oliver Dorr, Marina dos Santos Guilherme, Christian Troidl, Christoph Liebetrau, Sandra Voss, Robert Voswinckel, Ralph T. Schermuly, Werner Seeger, Friedr
    Eur Respir J. 2016;48:962.
    PubMed     Text format    


  38. LEVY M, Eyries M, Szezepanski I, Ladouceur M, et al
    Genetic analyses in a cohort of children with pulmonary hypertension.
    Eur Respir J. 2016 Sep 1. pii: ERJ-00211-2016. doi: 10.1183/13993003.00211-2016.
    PubMed     Text format     Abstract available


    August 2016
  39. NAGARAJ C, Tang B, Nagy BM, Papp R, et al
    Docosahexaenoic acid causes rapid pulmonary arterial relaxation via KCa channel-mediated hyperpolarisation in pulmonary hypertension.
    Eur Respir J. 2016 Aug 18. pii: ERJ-01814-2015. doi: 10.1183/13993003.01814-2015
    PubMed     Text format     Abstract available


  40. GAMEN E, Seeger W, Pullamsetti SS
    The emerging role of epigenetics in pulmonary hypertension.
    Eur Respir J. 2016 Aug 4. pii: ERJ-01714-2015. doi: 10.1183/13993003.01714-2015.
    PubMed     Text format     Abstract available



  41. ERJ August Podcast: management of chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2016;48:E68.
    PubMed     Text format    


    July 2016
  42. PARPALEIX A, Amsellem V, Houssaini A, Abid S, et al
    Role of interleukin-1 receptor 1/MyD88 signalling in the development and progression of pulmonary hypertension.
    Eur Respir J. 2016 Jul 13. pii: ERJ-01448-2015. doi: 10.1183/13993003.01448-2015
    PubMed     Text format     Abstract available


    June 2016
  43. HASSOUN PM, Nathan SD
    Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science.
    Eur Respir J. 2016;47:1615-7.
    PubMed     Text format    


    May 2016
  44. GERGES M, Gerges C, Lang IM
    How to define pulmonary hypertension due to left heart disease.
    Eur Respir J. 2016 May 12. pii: ERJ-00432-2016. doi: 10.1183/13993003.00432-2016
    PubMed     Text format    


    April 2016
  45. HOFFMANN J, Wilhelm J, Olschewski A, Kwapiszewska G, et al
    Microarray analysis in pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-02030-2015. doi: 10.1183/13993003.02030-2015
    PubMed     Text format     Abstract available


  46. NEDER JA, Ramos RP, Ota-Arakaki JS, Ferreira EM, et al
    Insights into ventilation-gas exchange coupling in chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-01948-2015. doi: 10.1183/13993003.01948-2015
    PubMed     Text format    


  47. MATHAI SC, Ghofrani HA, Mayer E, Pepke-Zaba J, et al
    Quality of life in patients with chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-01626-2015. doi: 10.1183/13993003.01626-2015
    PubMed     Text format     Abstract available


  48. OLIVEIRA RK, Agarwal M, Tracy JA, Karin AL, et al
    Age-related upper limits of normal for maximum upright exercise pulmonary haemodynamics.
    Eur Respir J. 2016;47:1179-88.
    PubMed     Text format     Abstract available


    March 2016
  49. GODINAS L, Lau EM, Chemla D, Lador F, et al
    Diagnostic concordance of different criteria for exercise pulmonary hypertension in subjects with normal resting pulmonary artery pressure.
    Eur Respir J. 2016 Mar 30. pii: ERJ-01678-2015. doi: 10.1183/13993003.01678-2015
    PubMed     Text format    


  50. MILARA J, Escriva J, Ortiz JL, Juan G, et al
    Vascular effects of sildenafil in patients with pulmonary fibrosis and pulmonary hypertension: an ex vivo/in vitro study.
    Eur Respir J. 2016 Mar 23. pii: ERJ-01259-2015. doi: 10.1183/13993003.01259-2015
    PubMed     Text format     Abstract available


    February 2016
  51. LAHM T
    Sex differences in pulmonary hypertension: are we cleaning up the mess?
    Eur Respir J. 2016;47:390-3.
    PubMed     Text format    


  52. TOSHNER M
    Genetic testing in pulmonary hypertension: how should our clinical practice reflect recent advances?
    Eur Respir J. 2016;47:388-9.
    PubMed     Text format    


  53. MALENFANT S, Perros F
    beta-blockers in pulmonary arterial hypertension: generation might matter.
    Eur Respir J. 2016;47:682-4.
    PubMed     Text format    


  54. PRICE LC, Wort SJ
    Earlier diagnosis and international registries may improve outcomes in pulmonary tumour thrombotic microangiopathy.
    Eur Respir J. 2016;47:690-1.
    PubMed     Text format    


  55. MERAD M, Savale L, Antoun S, Vincent F, et al
    Is there hope of improving the prognosis of pulmonary tumour thrombotic microangiopathy?
    Eur Respir J. 2016;47:688-90.
    PubMed     Text format    


  56. PUENTE-MAESTU L, Palange P, Casaburi R, Laveneziana P, et al
    Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement.
    Eur Respir J. 2016;47:429-60.
    PubMed     Text format     Abstract available


  57. RODRIGUEZ-ROISIN R, Bartolome SD, Huchon G, Krowka MJ, et al
    Inflammatory bowel diseases, chronic liver diseases and the lung.
    Eur Respir J. 2016;47:638-50.
    PubMed     Text format     Abstract available


    January 2016
  58. KOVACS G, Avian A, Olschewski H
    Proposed new definition of exercise pulmonary hypertension decreases false positive cases.
    Eur Respir J. 2016 Jan 7. pii: ERJ-01394-2015. doi: 10.1183/13993003.01394-2015.
    PubMed     Text format    


  59. QUILOT FM, Georges M, Favrolt N, Beltramo G, et al
    Pulmonary hypertension associated with ponatinib therapy.
    Eur Respir J. 2016 Jan 7. pii: ERJ-01110-2015. doi: 10.1183/13993003.01110-2015.
    PubMed     Text format    


  60. SOMMER N, Strielkov I, Pak O, Weissmann N, et al
    Oxygen sensing and signal transduction in hypoxic pulmonary vasoconstriction.
    Eur Respir J. 2016;47:288-303.
    PubMed     Text format     Abstract available


    December 2015
  61. SABOOR F, Reckmann AN, Tomczyk CU, Peters DM, et al
    Nestin-expressing vascular wall cells drive development of pulmonary hypertension.
    Eur Respir J. 2015 Dec 23. pii: ERJ-00574-2015. doi: 10.1183/13993003.00574-2015
    PubMed     Text format     Abstract available


  62. GIRERD B, Montani D, Jais X, Eyries M, et al
    Genetic counselling in a national referral centre for pulmonary hypertension.
    Eur Respir J. 2015 Dec 23. pii: ERJ-00717-2015. doi: 10.1183/13993003.00717-2015
    PubMed     Text format     Abstract available



  63. "2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)."
    Eur Respir J. 2015;46:1855-6.
    PubMed     Text format    


  64. SAVALE L, Chaumais MC, Sitbon O, Humbert M, et al
    Pulmonary arterial hypertension in patients treated with interferon.
    Eur Respir J. 2015;46:1851-3.
    PubMed     Text format    


  65. PRELLA M, Yerly P, Nicod LP, Aubert JD, et al
    Pulmonary arterial hypertension in patients treated with interferon.
    Eur Respir J. 2015;46:1849-51.
    PubMed     Text format    


    November 2015
  66. BARBERA JA, Blanco I
    Gaining insights into pulmonary hypertension in respiratory diseases.
    Eur Respir J. 2015;46:1247-50.
    PubMed     Text format    


    October 2015
  67. HUITEMA MP, Spee M, Vorselaars VM, Boerman S, et al
    Pulmonary artery diameter to predict pulmonary hypertension in pulmonary sarcoidosis.
    Eur Respir J. 2015 Oct 22. pii: ERJ-01319-2015. doi: 10.1183/13993003.01319-2015
    PubMed     Text format    



  68. ERJ October Podcast: new guidelines for diagnosis and treatment of pulmonary hypertension.
    Eur Respir J. 2015;46:E58.
    PubMed     Text format    


  69. LAU EM, Tamura Y, McGoon MD, Sitbon O, et al
    The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress.
    Eur Respir J. 2015;46:879-82.
    PubMed     Text format    


    September 2015
  70. CHEMLA D, Lau EM, Papelier Y, Attal P, et al
    Pulmonary vascular resistance and compliance relationship in pulmonary hypertension.
    Eur Respir J. 2015 Sep 4. pii: ERJ-00741-2015. doi: 10.1183/13993003.00741-2015.
    PubMed     Text format     Abstract available


  71. NAEIJE R, Vonk Noordegraaf A, Kovacs G
    Exercise-induced pulmonary hypertension: at last!
    Eur Respir J. 2015;46:583-6.
    PubMed     Text format    


    August 2015
  72. GALIE N, Humbert M, Vachiery JL, Gibbs S, et al
    2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): E
    Eur Respir J. 2015 Aug 29. pii: ERJ-01032-2015. doi: 10.1183/13993003.01032-2015
    PubMed     Text format    


  73. BREWIS MJ, Church AC, Johnson MK, Peacock AJ, et al
    Severe pulmonary hypertension in lung disease: phenotypes and response to treatment.
    Eur Respir J. 2015 Aug 20. pii: ERJ-02307-2014. doi: 10.1183/13993003.02307-2014
    PubMed     Text format     Abstract available


  74. RAGHU G, Nathan SD, Behr J, Brown KK, et al
    Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction.
    Eur Respir J. 2015 Aug 6. pii: ERJ-01537-2014. doi: 10.1183/13993003.01537-2014.
    PubMed     Text format     Abstract available


  75. TIEDE SL, Gall H, Dorr O, Troidl C, et al
    New potential diagnostic biomarkers for pulmonary hypertension.
    Eur Respir J. 2015 Aug 6. pii: ERJ-00187-2015. doi: 10.1183/13993003.00187-2015.
    PubMed     Text format     Abstract available


  76. HASSOUN PM
    Inflammation in chronic thromboembolic pulmonary hypertension: accomplice or bystander in altered angiogenesis?
    Eur Respir J. 2015;46:303-6.
    PubMed     Text format    


  77. FRANTZ RP
    Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm.
    Eur Respir J. 2015;46:299-302.
    PubMed     Text format    


    July 2015
  78. KUMAR N, Price LC, Montero MA, Dimopoulos K, et al
    Pulmonary tumour thrombotic microangiopathy: unclassifiable pulmonary hypertension?
    Eur Respir J. 2015 Jul 23. pii: ERJ-00052-2015. doi: 10.1183/13993003.00052-2015
    PubMed     Text format    


    June 2015
  79. QUARCK R, Wynants M, Verbeken E, Meyns B, et al
    Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2015 Jun 25. pii: ERJ-00099-2014. doi: 10.1183/09031936.00009914.
    PubMed     Text format     Abstract available


  80. KOSANOVIC D, Luitel H, Dahal BK, Cornitescu T, et al
    Chymase: a multifunctional player in pulmonary hypertension associated with lung fibrosis.
    Eur Respir J. 2015 Jun 25. pii: ERJ-00182-2015. doi: 10.1183/09031936.00018215.
    PubMed     Text format     Abstract available


  81. MANDERS E, Ruiter G, Bogaard HJ, Stienen GJ, et al
    Quadriceps muscle fibre dysfunction in patients with pulmonary arterial hypertension.
    Eur Respir J. 2015;45:1737-40.
    PubMed     Text format    


  82. ROBERTSON HT
    Dead space: the physiology of wasted ventilation.
    Eur Respir J. 2015;45:1704-16.
    PubMed     Text format     Abstract available


    May 2015
  83. HERVE P, Lau E, Sitbon O, Savale L, et al
    Criteria for diagnosis of exercise pulmonary hypertension.
    Eur Respir J. 2015 May 28. pii: ERJ-00219-2015.
    PubMed     Text format     Abstract available


    April 2015
  84. TAMURA Y, Kimura M, Takei M, Ono T, et al
    Oral vasopressin receptor antagonist tolvaptan in right heart failure due to pulmonary hypertension.
    Eur Respir J. 2015 Apr 30. pii: ERJ-00449-2015.
    PubMed     Text format    


  85. TRIP P, Rain S, Handoko ML, van der Bruggen C, et al
    Clinical relevance of right ventricular diastolic stiffness in pulmonary hypertension.
    Eur Respir J. 2015 Apr 16. pii: ERJ-01567-2014.
    PubMed     Text format     Abstract available


  86. HUERTAS A, Tu L, Thuillet R, Le Hiress M, et al
    Leptin signalling system as a target for pulmonary arterial hypertension therapy.
    Eur Respir J. 2015;45:1066-80.
    PubMed     Text format     Abstract available


    March 2015
  87. PLOEGSTRA MJ, Berger RM
    What's the (end) point?
    Eur Respir J. 2015;45:854-5.
    PubMed     Text format    


  88. VENTETUOLO CE, Kawut SM
    What's the (end) point?
    Eur Respir J. 2015;45:853-4.
    PubMed     Text format    


  89. HOUSTON BA, Tedford RJ
    Stressing the stepchild: assessing right ventricular contractile reserve in pulmonary arterial hypertension.
    Eur Respir J. 2015;45:604-7.
    PubMed     Text format    


  90. SHARMA T, Lau EM, Choudhary P, Torzillo PJ, et al
    Dobutamine stress for evaluation of right ventricular reserve in pulmonary arterial hypertension.
    Eur Respir J. 2015;45:700-8.
    PubMed     Text format     Abstract available


    February 2015
  91. FUKIHARA J, Kondoh Y, Taniguchi H, Kimura T, et al
    Pulmonary hypertension associated with obliterative phlebitis in IgG4-related lung disease.
    Eur Respir J. 2015 Feb 5. pii: ERJ-01303-2014.
    PubMed     Text format    


    January 2015
  92. MORRIS NR, Seale H, Harris J, Hall K, et al
    Serious adverse events during a 6-min walk test in patients with pulmonary hypertension.
    Eur Respir J. 2015 Jan 22. pii: ERJ-01469-2014.
    PubMed     Text format    


  93. NAEIJE R, Ghio S
    More on the right ventricle in pulmonary hypertension.
    Eur Respir J. 2015;45:33-5.
    PubMed     Text format    


  94. COURAND PY, Pina Jomir G, Khouatra C, Scheiber C, et al
    Prognostic value of right ventricular ejection fraction in pulmonary arterial hypertension.
    Eur Respir J. 2015;45:139-49.
    PubMed     Text format     Abstract available


    December 2014
  95. GUIHAIRE J, Haddad F, Noly PE, Boulate D, et al
    Right ventricular reserve in a piglet model of chronic pulmonary hypertension.
    Eur Respir J. 2014 Dec 10. pii: ERJ-00813-2014.
    PubMed     Text format     Abstract available


  96. DE PERROT M, Mayer E
    Chronic thromboembolic pulmonary hypertension: do we need a new definition?
    Eur Respir J. 2014;44:1401-3.
    PubMed     Text format    


    November 2014
  97. SIMONNEAU G, D'Armini AM, Ghofrani HA, Grimminger F, et al
    Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2).
    Eur Respir J. 2014 Nov 13. pii: erj00871-2014.
    PubMed     Text format     Abstract available


  98. AUGER WR, Kim NH
    Microvascular disease in chronic thromboembolic pulmonary hypertension: the story continues.
    Eur Respir J. 2014;44:1121-2.
    PubMed     Text format    


    October 2014
  99. QUARCK R, Delcroix M
    Is inflammation a potential therapeutic target in chronic thromboembolic pulmonary hypertension?
    Eur Respir J. 2014;44:842-5.
    PubMed     Text format    


    September 2014
  100. HELD M
    Pulmonary hypertension-specific therapy in patients with chronic respiratory insufficiency.
    Eur Respir J. 2014;44:821-2.
    PubMed     Text format    


  101. COTTIN V, Lorillou M, Khouatra C, Traclet J, et al
    Pulmonary hypertension-specific therapy in patients with chronic respiratory insufficiency.
    Eur Respir J. 2014;44:819-21.
    PubMed     Text format    


    August 2014
  102. DORFMULLER P, Gunther S, Ghigna MR, Thomas de Montpreville V, et al
    Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature.
    Eur Respir J. 2014 Aug 19. pii: erj01691-2013.
    PubMed     Text format     Abstract available


  103. NATHAN SD
    Hypersensitivity pneumonitis and pulmonary hypertension: how the breeze affects the squeeze.
    Eur Respir J. 2014;44:287-8.
    PubMed     Text format    


  104. NAEIJE R, D'Alto M
    Sex matters in pulmonary arterial hypertension.
    Eur Respir J. 2014;44:553-4.
    PubMed     Text format    


  105. MONNERET D
    Cytokines in pulmonary arterial hypertension: consider sensitivity when using multiplex technology.
    Eur Respir J. 2014;44:547-9.
    PubMed     Text format    


    July 2014
  106. ZABINI D, Heinemann A, Foris V, Nagaraj C, et al
    Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients.
    Eur Respir J. 2014 Jul 17. pii: erj01450-2013.
    PubMed     Text format     Abstract available


    June 2014
  107. LEVARGE BL, Pomerantsev E, Channick RN
    Reliance on end-expiratory wedge pressure leads to misclassification of pulmonary hypertension.
    Eur Respir J. 2014 Jun 12. pii: erj02093-2013.
    PubMed     Text format     Abstract available


  108. MCGOON MD
    Upfront triple therapy for pulmonary arterial hypertension: is three a crowd or critical mass?
    Eur Respir J. 2014;43:1556-9.
    PubMed     Text format    


  109. SITBON O, Jais X, Savale L, Cottin V, et al
    Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study.
    Eur Respir J. 2014;43:1691-7.
    PubMed     Text format     Abstract available


  110. LAU EM, Abelson D, Dwyer N, Yu Y, et al
    Assessment of ventriculo-arterial interaction in pulmonary arterial hypertension using wave intensity analysis.
    Eur Respir J. 2014;43:1804-7.
    PubMed     Text format    


    May 2014
  111. NAEIJE R, Delcroix M
    Is the time constant of the pulmonary circulation truly constant?
    Eur Respir J. 2014;43:1541-2.
    PubMed     Text format    


  112. GRIGNOLA JC
    Is the time constant of the pulmonary circulation truly constant?
    Eur Respir J. 2014;43:1539-41.
    PubMed     Text format    


  113. MARTINOT JB, Guenard HJ
    TLNO/TLCO ratio is not the end of the road.
    Eur Respir J. 2014;43:1535-6.
    PubMed     Text format    


  114. HARBAUM L, Hennigs JK, Baumann HJ, Bokemeyer C, et al
    Complete resolution of idiopathic pulmonary arterial hypertension following chemotherapy.
    Eur Respir J. 2014;43:1513-5.
    PubMed     Text format    


  115. FUKUI S, Ogo T, Morita Y, Tsuji A, et al
    Right ventricular reverse remodelling after balloon pulmonary angioplasty.
    Eur Respir J. 2014;43:1394-402.
    PubMed     Text format     Abstract available


  116. GHIO S, Morsolini M, Corsico A, Klersy C, et al
    Pulmonary arterial compliance and exercise capacity after pulmonary endarterectomy.
    Eur Respir J. 2014;43:1403-9.
    PubMed     Text format     Abstract available


  117. SHIRAI Y, Tamura Y, Yasuoka H, Satoh T, et al
    IgG4-related disease in pulmonary arterial hypertension on long-term epoprostenol treatment.
    Eur Respir J. 2014;43:1516-9.
    PubMed     Text format    


  118. RAMOS RP, Ota-Arakaki JS, Alencar MC, Ferreira EV, et al
    Exercise oxygen uptake efficiency slope independently predicts poor outcome in pulmonary arterial hypertension.
    Eur Respir J. 2014;43:1510-2.
    PubMed     Text format    


  119. BOERRIGTER BG, Waxman AB, Westerhof N, Vonk-Noordegraaf A, et al
    Measuring central pulmonary pressures during exercise in COPD: how to cope with respiratory effects.
    Eur Respir J. 2014;43:1316-25.
    PubMed     Text format     Abstract available


    April 2014
  120. SOUZA R, Fernandes CJ, Hoeper MM
    Carbon monoxide diffusing capacity and the complexity of diagnosis in pulmonary arterial hypertension.
    Eur Respir J. 2014;43:963-5.
    PubMed     Text format    


  121. TRIP P, Girerd B, Bogaard HJ, de Man FS, et al
    Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension.
    Eur Respir J. 2014;43:1195-8.
    PubMed     Text format    


    March 2014
  122. HASSOUN PM
    Inflammation in pulmonary arterial hypertension: is it time to quell the fire?
    Eur Respir J. 2014;43:685-8.
    PubMed     Text format    


  123. CRACOWSKI JL, Chabot F, Labarere J, Faure P, et al
    Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension.
    Eur Respir J. 2014;43:915-7.
    PubMed     Text format    


  124. KLINE JA, Watts J, Courtney D, Lee YY, et al
    Severe pulmonary embolism decreases plasma L-arginine.
    Eur Respir J. 2014;43:906-9.
    PubMed     Text format    


  125. HERESI GA, Aytekin M, Hammel JP, Wang S, et al
    Plasma interleukin-6 adds prognostic information in pulmonary arterial hypertension.
    Eur Respir J. 2014;43:912-4.
    PubMed     Text format    


    February 2014
  126. MONTANI D, Girerd B, Gunther S, Riant F, et al
    Pulmonary arterial hypertension in familial hemiplegic migraine with ATP1A2 channelopathy.
    Eur Respir J. 2014;43:641-3.
    PubMed     Text format    


  127. VENTETUOLO CE, Praestgaard A, Palevsky HI, Klinger JR, et al
    Sex and haemodynamics in pulmonary arterial hypertension.
    Eur Respir J. 2014;43:523-30.
    PubMed     Text format     Abstract available


  128. PAULIN R, Meloche J, Courboulin A, Lambert C, et al
    Targeting cell motility in pulmonary arterial hypertension.
    Eur Respir J. 2014;43:531-44.
    PubMed     Text format     Abstract available


    August 2013
  129. RUTTENS D , Verleden SE, Goeminne PC, Poels K, et al
    Smoking resumption after lung transplantation: need for standardized screening and importance for long-term outcome.
    Eur Respir J. 2013.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: